Publications by authors named "Eileen Bird"

Claim this Profile
B
Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding.
Pancras C Wong, Dietmar Seiffert, J Eileen Bird, Carol A Watson, Jeffrey S Bostwick

Sci Transl Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does plexin-B1, a semaphorin 4D receptor, play a role in thrombosis?
Eileen Bird, Patricia L Smith, Dietmar Seiffert, George C Psaltis, Jinwen Huang

Thromb Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A platelet target for venous thrombosis? P2Y1 deletion or antagonism protects mice from vena cava thrombosis.
J Eileen Bird, Xinkang Wang, Patricia L Smith, Frank Barbera, Christine Huang

J Thromb Thrombolysis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher trait.
J Eileen Bird, Patricia L Smith, Xinkang Wang, William A Schumacher, Frank Barbera

Thromb Haemost· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding response induced by anti-thrombotic doses of a phosphoinositide 3-kinase (PI3K)-β inhibitor in mice.
J Eileen Bird, Patricia L Smith, Jeffrey S Bostwick, Petia Shipkova, William A Schumacher

Thromb Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis.
J Eileen Bird, Mary R Giancarli, Nick Allegretto, Frank Barbera, Pancras Wong

Thromb Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential.
Saleem Ahmad, Cort S Madsen, Philip D Stein, Evan Janovitz, Christine Huang, Eileen Bird

J Med Chem· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is exogenous tissue plasminogen activator necessary for antithrombotic efficacy of an inhibitor of thrombin activatable fibrinolysis inhibitor (TAFI) in rats?
Eileen Bird, James Tamura, Jeffrey S Bostwick, Thomas E Steinbacher, Anne Stewart

Thromb Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis.
Xinkang Wang, Patricia L Smith, Mei-Yin Hsu, Joseph A Tamasi, Eileen Bird

J Thromb Thrombolysis· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel dual action AT1 and ETA receptor antagonists reduce blood pressure in experimental hypertension.
Mark C Kowala, Natesan Murugesan, John Tellew, Kenneth Carlson, Hossain Monshizadegan, Eileen Bird

J Pharmacol Exp Ther· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonist.
Natesan Murugesan, Zhengxiang Gu, Steven Spergel, Marian Young, Ping Chen, Eileen Bird

J Med Chem· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis